Table 3.
Event | Dabigatran (no. of patients) | Warfarin (no of patients) | Relative risk (95 % confidence interval) | P value |
---|---|---|---|---|
Dense SEC | ||||
At baseline | 6 (40) | 3 (25) | 0.50 (0.1–2.6) | 0.34 |
At the end | 7 (46.7) | 3 (25) | 0.38 (0.1–2.0) | 0.23 |
Resolution of SECa | 1 (6.7) | 1 (8.3) | 1.30 (0.1–22) | 0.70 |
New SECb | 2 (13.3) | 1 (8.3) | 0.60 (0.1–7.4) | 0.58 |
Mean TTR (%) | NA | 66.5 ± 7 | NA | NA |
Values are number (%) unless indicated otherwise
NA not applicable, SEC spontaneous echo contrast, TEE transesophageal echocardiogram, TTR time in therapeutic range
aSEC positive and negative in the first and last TEE, respectively
bSEC negative and positive in the first and last TEE, respectively